News coverage about Varex Imaging (NASDAQ:VREX) has been trending somewhat positive this week, according to Accern Sentiment. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Varex Imaging earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 45.7071120830134 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the media headlines that may have effected Accern Sentiment’s rankings:
- Recent Analysis Shows Alexander’s, American National Insurance, VAREX IMAGING, Banner, Instructure, and Heska Market Influences — Renewed Outlook, Key Drivers of Growth (finance.yahoo.com)
- Analysts Anticipate Varex Imaging (VREX) Will Post Quarterly Sales of $202.55 Million (americanbankingnews.com)
- Zacks: Varex Imaging (VREX) Given $38.50 Consensus Target Price by Analysts (americanbankingnews.com)
- $0.53 EPS Expected for Varex Imaging (VREX) This Quarter (americanbankingnews.com)
- Varex Imaging (VREX) Presents At Bank Of America Merrill Lynch 2018 Healthcare Conference – Slideshow (seekingalpha.com)
A number of research firms have commented on VREX. Zacks Investment Research cut Varex Imaging from a “buy” rating to a “hold” rating in a report on Thursday, May 10th. Sidoti began coverage on Varex Imaging in a report on Thursday, April 19th. They set a “neutral” rating on the stock.
Shares of Varex Imaging stock opened at $37.43 on Friday. The stock has a market cap of $1.44 billion, a PE ratio of 20.79, a PEG ratio of 2.05 and a beta of 2.46. The company has a quick ratio of 1.46, a current ratio of 3.25 and a debt-to-equity ratio of 0.96. Varex Imaging has a twelve month low of $27.80 and a twelve month high of $43.76.
Varex Imaging (NASDAQ:VREX) last issued its quarterly earnings data on Thursday, May 3rd. The company reported $0.45 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.45. The firm had revenue of $201.20 million during the quarter, compared to analyst estimates of $187.33 million. Varex Imaging had a return on equity of 16.74% and a net margin of 6.43%. The business’s quarterly revenue was up 30.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.43 earnings per share. analysts anticipate that Varex Imaging will post 1.85 earnings per share for the current fiscal year.
In related news, SVP Kimberley E. Honeysett sold 2,000 shares of Varex Imaging stock in a transaction dated Monday, April 16th. The stock was sold at an average price of $37.68, for a total value of $75,360.00. Following the completion of the transaction, the senior vice president now owns 916 shares in the company, valued at $34,514.88. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Kevin Bruce Yankton sold 862 shares of Varex Imaging stock in a transaction dated Monday, May 14th. The stock was sold at an average price of $37.00, for a total value of $31,894.00. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.
About Varex Imaging
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers, and buckys.
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.